WILLOW LABORATORIES

Lobbying for WILLOW LABORATORIES · technology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · posted Apr 1, 2026

Lobbying activity 3

Health Issues

Support for coverage and reimbursement for diabetes prevention and wellness technologies; patient safety; support for PBM reform and corporate governance.

Medicare/Medicaid

Support for increased Medicare and Medicaid coverage and reimbursement for diabetes prevention technologies

Financial Institutions/Investments/Securities

corporate governance and transparency

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.